CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 144 enrolled
Drug / intervention
ATLANTIS Abutmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02496091
NCT02496091N/ACompleted

A Retrospective Multicenter Study Evaluating ATLANTIS™ Abutments on Implants From Four Manufacturers

Dentsply Sirona Implants and Consumables·observational·Posted Jul 14, 2015·Updated Apr 28, 2020

In Brief

An observational study evaluating ATLANTIS Abutment for Dental Implants. Completed, enrolled 144 participants across 6 sites.

Detailed Summary

The study is designed as a retrospective and multi-center study. The study population is US individuals previously restored with titanium and gold-shaded titanium ATLANTIS abutments. The study includes retrospective data collection from the medical records and data collection from one prospective study visit with a clinical examination.The primary objective is to evaluate success. Success is defined as that the study implant and abutment are in situ and no Adverse Device Effects related to the study implant, abutment or adjacent peri-implant tissues are reported during the study.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDental Implants
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 14, 2015
Enrollment StartAug 31, 2015
Primary CompletionMar 30, 2018
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 11.0 years ago

Interventions

ATLANTIS Abutmentdevice